Barth Syndrome Treatment Market Revenue Expected to Reach US$ 662.3 Million
The Barth Syndrome Treatment Market is advancing due to breakthroughs in rare disease genomics and precision medicine. Increasing clinical trials and patient registries are improving understanding of disease progression. Supportive therapies dominate currently, but disease-modifying treatments are emerging. Government support and orphan drug policies are strengthening market expansion. Click here for more information: https://market.us/report/barth-syndrome-treatment-market/